Glaukos Competitors and Similar CompaniesClear all

Glaukos's competitors and similar companies include Haemonetics.
Glaukos
Glaukos
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
Haemonetics
Haemonetics
Haemonetics is a provider of medical products and solutions.
Founding Date
Founding Date
1998
Founding Date
1971
Type
Type
Public
Type
Public
Tags
Locations
Locations
Aliso Viejo, US HQ
Buenos Aires, AR
Heatherton, AU
Sao Paulo, BR
Richmond Hill, CA
San José, CR
Wiesbaden, DE
see more
Locations
Boston, US HQ
North Ryde, AU
Edmonton, CA
Québec, CA
Beijing, CN
Shanghai, CN
Brno, CZ
see more
Employees
Employees
90716% increase
Employees
3,65721% increase
Valuation ($)
Valuation ($)
7.6 b
Valuation ($)
3.7 b

Financial

Revenue (est.)
Revenue (est.)
$507.4m (FY, 2025)
Revenue (est.)
$1.4b (FY, 2025)
Cost of goods
Cost of goods
$111.8m (FY, 2025)
Cost of goods
$611.9m (FY, 2025)
Gross profit
Gross profit
$282.8m (FY, 2025)
Gross profit
$749m (FY, 2025)
Net income
Net income
($187.7m) (FY, 2025)
Net income
$167.7m (FY, 2025)

Operating

Facility Space Leased, sq. ft.
Facility Space Leased, sq. ft.
318 k (FY, 2022)
Facility Space Leased, sq. ft.
885.4 k (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Haemonetics
HQ
Boston, US
Employees
3,657↑ 21% increase

Haemonetics is a provider of medical products and solutions.

View company